The diagnostic potential of novel biomarkers of hypertension in men

12Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Introduction: The present study aimed to evaluate the diagnostic usefulness of selected novel parameters as biomarkers of hypertension: miR-145-5p, miR-1-3p, miR-423-5p, PCSK9, MyBPC3, NOX1, and CYBb, and NCF2, DNase 1, anti-MPO and anti-PR3 antibodies. Methods: We present the data of men with normal blood pressure, diagnosed hypertension, confirmed hypertension, and hypertension and coexisting coronary artery disease. Results: Elevated levels of miR-145-5p, miR-1-3p, and miR-423-5p and high levels of PCSK9, MyBPC3, and DNase 1 were observed in all groups of hypertensive men. We showed decreased levels of NOX1 and CYBb, and an elevated level of NCF2. Conclusions: PCSK9 shows the greatest potential as an early biomarker of screening-detected hypertension.

Cite

CITATION STYLE

APA

Charkiewicz, A. E., Garley, M., Ratajczak-Wrona, W., Jabłońska, E., Miltyk, W., Motyka, J., & Omeljaniuk, W. J. (2022). The diagnostic potential of novel biomarkers of hypertension in men. Archives of Medical Science, 18(6), 1666–1671. https://doi.org/10.5114/aoms/153500

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free